Data derived from PhenomiR
PubMed ID | disease | disease class | tissue | expression | foldchange max | foldchange min | genes | study design | method |
17363563 |
Colorectal cancer - 114500 |
Cancer |
Colo-201 cell |
miRNA downregulation |
- |
13.0 |
- |
Cell culture study |
quantitative PCR
|
17363563 |
Glioblastoma multiforme, somatic - 137800 |
Cancer |
U-251 cell |
miRNA downregulation |
- |
7.0 |
- |
Cell culture study |
quantitative PCR
|
18458333 |
Ovarian cancer - 604370 (Epithelial ovarian cancer - 0) |
Cancer |
ovary |
miRNA downregulation |
- |
- |
- |
Cell culture study |
miRNA microarray
|
17942673 |
Duchenne muscular dystrophy - 310200 |
Muscular |
muscle |
miRNA overexpression |
- |
5.77 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2A - 253600 |
Muscular |
muscle |
miRNA overexpression |
- |
3.48 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Muscular dystrophy, limb-girdle, type 2B - 253601 |
Muscular |
muscle |
miRNA overexpression |
- |
5.72 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Miyoshi myopathy - 254130 |
Muscular |
muscle |
miRNA overexpression |
- |
2.44 |
- |
Patient study phenotype-control |
miRNA microarray
|
17942673 |
Myopathy, nemaline, 3 - 161800 |
Muscular |
muscle |
miRNA overexpression |
- |
14.78 |
- |
Patient study phenotype-control |
miRNA microarray
|
17998940 |
Cervical cancer, somatic - 603956 |
Cancer |
CaSki cell |
miRNA downregulation |
- |
4.2 |
- |
Cell culture study |
miRNA microarray
|
16192569 |
Breast cancer - 114480 |
Cancer |
T-47D cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA overexpression |
- |
1.7223 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA overexpression |
- |
1.3543 |
- |
Patient study phenotype-control |
miRNA microarray
|
17243163 |
Muscular - 0 (Uterine leiomyoma - 0) |
Muscular |
myoma cell |
miRNA downregulation |
- |
1.34409 |
- |
Patient study phenotype-control |
miRNA microarray
|
16192569 |
Breast cancer - 114480 |
Cancer |
SK-BR-3 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA overexpression |
- |
57.83 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA downregulation |
- |
11.1111 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
18337557 |
Leukemia, acute myeloid - 601626 |
Cancer |
bone marrow |
miRNA downregulation |
- |
14.2857 |
- |
Patient study phenotype-phenotype |
quantitative PCR
|
16754881 |
Breast cancer - 114480 |
Cancer |
breast epithelium |
miRNA overexpression |
- |
- |
- |
Patient study phenotype-control |
array CGH
|
16754881 |
Melanoma and neural system tumor syndrome - 155755 |
Cancer |
cell culture |
miRNA downregulation |
- |
- |
- |
Cell culture study |
array CGH
|
16192569 |
Breast cancer - 114480 |
Cancer |
MCF-7 cell |
miRNA downregulation |
- |
25.0 |
- |
Cell culture study |
quantitative PCR
|
17922033 |
Cancer - 0 (Leiomyosarcoma - 0) |
Cancer |
muscle |
miRNA downregulation |
- |
4.34783 |
- |
Patient study phenotype-control |
quantitative PCR
|
17922033 |
Rhabdomyosarcoma - 268210 |
Cancer |
myoblast |
miRNA overexpression |
- |
24.27 |
- |
Patient study phenotype-control |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-231 cell |
miRNA downregulation |
- |
50.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Breast cancer - 114480 |
Cancer |
MDA-MB-361 cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PC-3 cell |
miRNA downregulation |
- |
16.6667 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
PPC-1 cell |
miRNA downregulation |
- |
33.3333 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
Tsu-Pr1 cell |
miRNA downregulation |
- |
33.3333 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Prostate cancer - 176807 |
Cancer |
LNCaP cell |
miRNA downregulation |
- |
100.0 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
1.75439 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Squamous cell carcinoma, head and neck - 601400 |
Cancer |
squamous cell carcinoma cell line |
miRNA downregulation |
- |
5.26316 |
- |
Cell culture study |
quantitative PCR
|
16737555 |
- |
- |
fibroblast |
miRNA overexpression |
- |
- |
- |
Bioprocess study |
miRNA microarray
|
16192569 |
Pancreatic cancer - 260350 |
Cancer |
PANC-1 cell |
miRNA overexpression |
- |
2.62 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
lung cancer cell line |
miRNA overexpression |
- |
1.14 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Hematological - 0 |
Hematological |
K-562 cell |
miRNA downregulation |
- |
3.33333 |
- |
Cell culture study |
quantitative PCR
|
16192569 |
Lung cancer - 211980 |
Cancer |
A-549 cell |
miRNA downregulation |
- |
3.33333 |
- |
Cell culture study |
quantitative PCR
|